Shinpoong Pharmaceutical announced 2025 goals at its Seoul and Ansan ceremonies, aiming for 24% sales growth via efficiency, new products, and overseas expansion. Key strategies include R&D enhancement, launching new drugs like Hyal Flex Inj. and Avosial, and strengthening global presence with Otaplimastat and existing drugs.